Green SM, Mostaghel EA, Nelson PS. Androgen action and metabolism in prostate cancer. Mol Cell Endocrinol. 2012;360:3–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001;1:34–45.

Article  CAS  PubMed  Google Scholar 

Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, et al. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis. 2012;33:1391–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002;52:154–79.

Article  PubMed  Google Scholar 

Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, et al. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. J Biomed Sci. 2011;18:63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, et al. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res. 2009;69:2305–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu R, Dunn TA, Wei S, Isharwal S, Veltri RW, Humphreys E, et al. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res. 2009;69:16–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugiura M, Sato H, Okabe A, Fukuyo M, Mano Y, Shinohara KI, et al. Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer. Transl Oncol. 2021;14:100915.

Article  CAS  PubMed  Google Scholar 

Cato L, de Tribolet-Hardy J, Lee I, Rottenberg JT, Coleman I, Melchers D, et al. ARv7 represses tumor-suppressor genes in castration-resistant prostate cancer. Cancer Cell. 2019;35:401–13.e6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rizzo A, Mollica V, Rosellini M, Marchetti A, Ricci AD, Fiorentino M, et al. Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: a meta-analysis of prospective clinical trials. Pathol Res Pract. 2021;222:153440.

Article  CAS  PubMed  Google Scholar 

Li Q, Wang Z, Yi J, Shen H, Yang Z, Yan L, et al. Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: a systematic review and meta-analysis. Transl Oncol. 2021;14:101145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong D, Sethi S, Li Y, Chen W, Sakr WA, Heath E, et al. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes. Prostate. 2015;75:161–74.

Article  CAS  PubMed  Google Scholar 

Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. New Engl J Med. 2014;371:1028–38.

Article  PubMed  Google Scholar 

Qu F, Xie W, Nakabayashi M, Zhang H, Jeong SH, Wang X, et al. Association of AR-V7 and prostate-specific antigen RNA levels in blood with efficacy of abiraterone acetate and enzalutamide treatment in men with prostate cancer. Clin Cancer Res. 2017;23:726–34.

Article  CAS  PubMed  Google Scholar 

Huang WJ, Huang CH, Wu CL, Lin JK, Chen YW, Lin CL, et al. Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells. J Agric Food Chem. 2007;55:7366–76.

Article  CAS  PubMed  Google Scholar 

Bhimani RS, Troll W, Grunberger D, Frenkel K. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res. 1993;53:4528–33.

CAS  PubMed  Google Scholar 

Natarajan K, Singh S, Burke TR Jr., Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA. 1996;93:9090–5.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ Jr., Hiipakka RA, et al. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prev Res. 2012;5:788–97.

Article  CAS  Google Scholar 

Lin HP, Lin CY, Huo C, Hsiao PH, Su LC, Jiang SS, et al. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Oncotarget. 2015;6:6684–707.

Article  PubMed  PubMed Central  Google Scholar 

Lin HP, Jiang SS, Chuu CP. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. PLoS ONE. 2012;7:e31286.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Tseng JC, Lin CY, Su LC, Fu HH, Yang SD, Chuu CP. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Oncotarget. 2016;7:38010–24.

Article  PubMed  PubMed Central  Google Scholar 

Tseng JC, Wang BJ, Wang YP, Kuo YY, Chen JK, Hour TC, et al. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells. Phytomedicine. 2023;116:154860.

Article  CAS  PubMed  Google Scholar 

Kuo YY, Huo C, Lin CY, Lin HP, Liu JS, Wang WC, et al. Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213. Cell Commun Signal. 2019;17:100.

Article  PubMed  PubMed Central  Google Scholar 

Tseng JC, Huang SH, Lin CY, Wang BJ, Huang SF, Shen YY, et al. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis. Cell Death Dis. 2020;11:376.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee CH, Ku JY, Ha JM, Bae SS, Lee JZ, Kim CS, et al. Transcript levels of androgen receptor variant 7 and ubiquitin-conjugating enzyme 2C in hormone sensitive prostate cancer and castration-resistant prostate cancer. Prostate. 2017;77:60–71.

Article  CAS  PubMed  Google Scholar 

Hu R, Lu C, Mostaghel EA, Yegnasubramanian S, Gurel M, Tannahill C, et al. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. Cancer Res. 2012;72:3457–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu J, Yu J, Rhodes DR, Tomlins SA, Cao X, Chen G, et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res. 2007;67:10657–63.

Article  CAS  PubMed  Google Scholar 

Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell. 2010;17:443–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu LL, Xie N, Sun S, Plymate S, Mostaghel E, Dong X. Mechanisms of the androgen receptor splicing in prostate cancer cells. Oncogene. 2014;33:3140–50.

Article  CAS  PubMed  Google Scholar 

Fan L, Zhang F, Xu S, Cui X, Hussain A, Fazli L, et al. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells. Proc Natl Acad Sci USA. 2018;115:E4584–E4593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J, et al. Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem. 2005;280:40916–24.

Article  CAS  PubMed  Google Scholar 

Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, et al. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 2000;60:6841–5.

CAS  PubMed  Google Scholar 

Chen S, Xu Y, Yuan X, Bubley GJ, Balk SP. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1. Proc Natl Acad Sci USA. 2006;103:15969–74.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Hsu FN, Chen MC, Chiang MC, Lin E, Lee YT, Huang PH, et al. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. J Biol Chem. 2011;286:33141–9.

Article